Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neurological Sciences
Published in: Neurological Sciences 2/2020

01-02-2020 | Alzheimer's Disease | Neurological Digression

The puzzle of preserved cognition in the oldest old

Author: Orso Bugiani

Published in: Neurological Sciences | Issue 2/2020

Login to get access

Abstract

Although epidemiological studies predict an exponential increase in the prevalence of dementia with age, recent studies have demonstrated that the oldest old are actually less frequently affected by dementia than the younger elderly. To explain this, I suggest a parallel between brain ageing and Alzheimer’s disease (AD) and assume that theories concerning the brain’s vulnerability to AD and its individual variability may also explain why some of the oldest old remain cognitively efficient. Some theories argue that AD is due to the continuing presence of the immature neurones vulnerable to amyloid beta protein (Aß) that are normally involved in brain development and then removed as a result of cell selection by the proteins associated with both brain development and AD. If a dysfunction in cell selection allows these immature neurones to survive, they degenerate early as a result of the neurotoxic action of Aß accumulation, which their mature counterparts can withstand. Consequently, age at the time of onset of AD and its clinical presentations depend on the number and location of such immature cells. I speculate that the same mechanism is responsible for the variability of normal brain ageing: the oldest old with well-preserved cognitive function are people genetically programmed for extreme ageing who have benefited from better cell selection during prenatal and neonatal life and therefore have fewer surviving neurones vulnerable to amyloid-promoted degeneration, whereas the process of early life cell selection was less successful in the oldest old who develop dementia.
Literature
1.
United Nations Department of Economic and Social Affairs, Population Division. World Population Prospect: The 2015 Revision. United Nations, New York 2015
2.
3.
von Faber M, Bootsma-van der Wiel A, van Exel E et al (2001) Successful ageing in the oldest old. Who can be characterized as successfully aged? Arch Intern Med 161:2694–2700
4.
Andersen-Ranberg K, Schroll M, Jeune B (2011) Healthy centenarians do not exist, but autonomous centenarians do: a population-based study of morbidity among Danish centenarians. J Am Geriatr Soc 49:900–908
5.
6.
7.
Perls T (2004) Dementia-free centenarians. Exp Gerontol 39:1587–1593PubMed
8.
Yang Z, Slavin MJ, Sachdev PS (2013) Dementia in the oldest old. Nat Rev Neurol 9:382–393PubMed
9.
Qiu C, Fratiglioni L (2018) Ageing without dementia is achievable: current evidence from epidemiological research. J Alzheimers Dis 62:933–942PubMedPubMedCentral
10.
Middelton LE, Grinberg LT, Miller B et al (2011) Neuropathologic features associated with Alzheimer disease diagnosis. Neurology 77:1737–1744
11.
Lucca U, Tettamanti M, Logroscino G et al (2015) Prevalence of dementia in the oldest old: the Monzino 80-plus population-based study. Alzheimers Dement 11:258–270PubMed
12.
Polvikoski T, Sulkava R, Myllykangas L et al (2001) Prevalence of Alzheimer’s disease in very elderly people. A prospective neuropathological study. Neurology 56:1690–1696PubMed
13.
Nelson PT, Jicha GA, Schmitt FA et al (2007) Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles “do count” when stageing disease severity. J Neuropathol Exp Neurol 66:1136–1146PubMedPubMedCentral
14.
15.
Kawas CH, Kim RC, Sonnen JA et al (2015) Multiple pathologies are common and related to dementia in the oldest-old. The 90+ Study. Neurology 85:535–542PubMedPubMedCentral
16.
Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC, CFAS) (2001) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357:169–175
17.
Schneider JA, Arvanitakis Z, Bang W, Bennett DA (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 68:2197–2204
18.
Kovacs GG, Milenkovic I, Wöhrer A et al (2013) Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series. Acta Neuropathol 126:365–384PubMed
19.
Hof PR, Morrison JH (2004) The ageing brain: morphomolecular senescence and cortical circuits. Trends Neurosci 27:607–613PubMed
20.
Peters A, Sethares C, Luebke JI (2008) Synapses are lost during ageing in the primate prefrontal cortex. Neuroscience 152:970–981PubMed
21.
Adalbert R, Coleman MP (2013) Axon pathology in age-related neurodegenerative disorders. Neuropathol Appl Neurobiol 39:90–108PubMed
22.
Marner E, Nyengaard JR, Tang Y, Pakkenberg B (2003) Marked loss of myelinated nerve fibers in the human brain with age. J Comp Neurol 462:144–152PubMed
23.
Pakkenberg B, Gundersen HJ (1997) Neocortical neurone number in humans: effect of sex and age. J Comp Neurol 384:312–320PubMed
24.
Burke SN, Barnes CA (2006) Neural plasticity in the ageing brain. Nat Rev Neurosci 7:30–40PubMed
25.
26.
Chance SA, Casanova MF, Swicata AE, Crow TJ, Esiri MM (2006) Minicolumn thinning in temporal lobe association cortex but not primary auditory cortex in normal human ageing. Acta Neuropathol 111:459–464PubMed
27.
28.
Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960–969PubMed
29.
Rajmohan R, Reddy PH (2017) Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer’s disease neurones. J Alzheimers Dis 57:975–999PubMedPubMedCentral
30.
Gardner RC, Valcour V, Yaffe K (2013) Dementia in the oldest-old: a multi-factorial and growing public health issue. Alzheimers Res Ther 5:27–37PubMedPubMedCentral
31.
Katzman R, Terry R, De Teresa R et al (1998) Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 23:138–144
32.
Knopman DS, Parisi JE, Salviati A et al (2003) Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 62:1087–1095
33.
Balasubramanian AB, Kawas CH, Peltz CB, Brookmeyer R, Corrada MM (2012) Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia. Neurology 79:915–921PubMedPubMedCentral
34.
Bennett DA, Schneider JA, Arvanitakis Z et al (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66:1837–1844PubMed
35.
Murray ME, Lowe VJ, Graff-Radford NR et al (2015) Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum. Brain 138:1370–1381PubMedPubMedCentral
36.
Perez-Nieves BG, Stein TD, Tai H-C et al (2013) Dissecting phenotypic traits linked to human resilience to Alzheimer’s pathology. Brain 136:2510–2526
37.
Haroutunian V, Schnaider-Beeri M, Schmeidler J et al (2008) Role of the neuropathology of Alzheimer disease in dementia of the oldest-old. Arch Neurol 65:1211–1217
38.
Savva GM, Wharton SB, Ince PG et al (2009) Age, neuropathology, and dementia. N Engl J Med 360:2302–2309PubMed
39.
Corrada MM, Berlau DJ, Kawas CH (2012) A population-based clinicopathological study in the oldest-old: the 90+ study. Curr Alzheimer Res 9:709–717PubMedPubMedCentral
40.
41.
Ritchie K, Kildea D (1995) Is senile dementia “age-related” or “ageing-related”? Evidence from meta-analysis of dementia prevalence in the oldest old. Lancet 346:931–934PubMed
42.
Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185PubMed
43.
Choi SH, Kim YH, Hebisch M et al (2014) A three-dimensional human neural cell culture model of Alzheimer’s disease. Nature 515:274–278PubMedPubMedCentral
44.
Bugiani O (2011) Alzheimer’s disease: ageing-related or age-related? New hypotheses from an old debate. Neurol Sci 32:1241–1247PubMed
45.
Sperling RA, Aisen PS, Beckett LA et al (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Ageing-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:280–292
46.
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259PubMed
47.
Jagust W (2013) Vulnerable neural systems and the borderland of brain ageing and neurodegeneration. Neurone 77:219–234
48.
49.
Eisele YS, Duyckaerts C (2016) Propagation of Aβ pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131:5–25PubMed
50.
51.
Alladi S, Xuereb J, Bak T et al (2007) Focal cortical presentations of Alzheimer’s disease. Brain 130:2636–2645PubMed
52.
Crook R, Verkkoniemi A, Perez-Tur J et al (1998) A variant of Alzheimer’s disease with spastic paraparesis and unusual plaques due to the deletion of exon 9 of presenilin 1. Nat Med 4:452–455PubMed
53.
Rabinovici GD, Jagust WJ, Furst AJ et al (2008) Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 64:388–401PubMedPubMedCentral
54.
Laforce R Jr, Tosun D, Ghosh P et al (2014) Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer’s pathology. Neuroimage: Clinical 4:508–516
55.
Murray ME, Graff-Radford NR, Ross OA et al (2011) Neuropathologically defined subtypes of Alzheimer’s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 10:785–796PubMedPubMedCentral
56.
Duyckaerts C (2011) Disentangling Alzheimer’s disease. Lancet Neurol 10:774–775PubMed
57.
Kemp PM, Holmes C, Hoffmann SMA et al (2009) Alzheimer’s disease: differences in tehnetium-99m HMPAO SPECT scan findings between early onset and late onset dementia. J Neurol Neurosurg Psychiatry 74:715–719
58.
Bäckman L, Jones S, Berger AK et al (2005) Cognitive impairment in preclinical Alzheimer’s disease: a meta-analysis. Neuropsychology 19:520–553PubMed
59.
Shaw P, Lerch JP, Pruessner JC et al (2007) Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol 6:494–500PubMed
60.
Dean DC III, Jerskey BA, Chen K et al (2014) Brain differences in infants at differential genetic risk for late-onset Alzheimer disease. A cross-sectional imaging study. JAMA Neurology 71:11–22PubMedPubMedCentral
61.
Flechsig P (1896) Gehirn und Seele. Veit & Comp, Leipzig
62.
Vogt C, Vogt O (1922) Erkrankungen der Großhirnrinde im Lichte der Topistik, Pathoklise und Pathoarchitektonik. J Psychol Neurol 28:1–171
63.
Arendt T, Brückner MK, Lösche A (2015) Regional mosaic genomic heterogeneity in the elderly and in Alzheimer’s disease as a correlate of neural vulnerability. Acta Neuropathol 130:501–510PubMed
64.
65.
Arendt T (2000) Alzheimer’s disease as a loss of differentiation control in a subset of neurones that retain immature features in the adult brain. Neurobiol Ageing 21:783–796
66.
Hunter S, Arendt T, Brayne C (2013) The senescence hypothesis of disease progression in Alzheimer dissease: an integrated matrix of disease pathways for FAD and SAD. Mol Neurobiol 48:556–570PubMed
67.
Lovell MA, Geiger H, Van Zant GE et al (2006) Isolation of neural precursor cells from Alzheimer’s disease and aged control post-mortem brain. Neurobiol Ageing 27:909–917
68.
Jin K, Peel AL, Mao XO et al (2004) Increased hippocampal neurogenesis in Alzheimer’s disease. Proc Natl Acad Sci U S A 101:343–347
69.
Li B, Yamamori H, Tatebayashi Y et al (2008) Failure of neural maturation in Alzheimer disease dentate gyrus. J Neuropathol Exp Neurol 67:78–84
70.
Reiner O, Shmueli A, Sapir T (2009) Neuronal migration and neurodegeneration: 2 sides of the same coin. Cereb Cortex 19:142–148
71.
Kovacs GG, Adle-Bassette H, Milenkovic I et al (2014) Linking pathways in the developing and ageing brain with neurodegeneration. Neuroscience 269:152–172PubMed
72.
Schaefers ATU, Teuchert-Noodt G (2016) Developmental neuroplasticity and the origin of neurodegenerative diseases. World J Biol Psychiat 17:587–599
73.
Porayette P, Gallego MJ, Kaltcheva MM et al (2009) Differential processing of amyloid-beta precursor protein directs human embryonic stem cell proliferation and differentiation into neuronal precursor cells. J Biol Chem 284:23806–23817PubMed
74.
Young-Pearse TL, Bai J, Chang R et al (2007) A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference. J Neurosci 27:14459–14469PubMed
75.
Nikolaev A, McLaughlin T, O’Leary DD, Tessier-Lavigne M (2009) APP binds DR6 to trigger axon pruning and neurone death via distinct caspases. Nature 457:981–989PubMedPubMedCentral
76.
Wines-Samuelson M, Shen J (2005) Presenilins in the developing, adult, and ageing cerebral cortex. Neuroscientist 11:441–451PubMed
77.
Johnson GVW, Stoothoff WH (2004) Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci 117:5721–5729PubMed
78.
Mehler MF, Gokhan S (2001) Developmental mechanisms in the pathogenesis of neurodegenerative diseases. Prog Neurobiol 63:337–363PubMed
79.
Di Fede G, Catania M, Morbin M et al (2009) A recessive mutations in the APP gene with dominant-negative effect on amyloidogenesis. Science 323:1473–1477PubMedPubMedCentral
80.
Bettens K, Sleegers K, Van Broeckhoven C (2013) Genetic insight in Alzheimer’s disease. Lancet Neurol 12:92–104PubMed
81.
Lambert JC, Ibrahim-Verbaas CA, Harold D et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45:1452–1458
82.
Karch CM, Cruchaga C, Goate A (2014) Alzheimer’s disease genetics: from the bench to the clinic. Neurone 83:11–26
83.
84.
Desikan RS, Schork AJ, Wang Y et al (2015) Genetic overlap between Alzheimer’s disease and Parkinson’s disease at the MAPT locus. Mol Psychiatry 20:1588–1595PubMedPubMedCentral
85.
Jun G, Ibrahim-Verbaas CA, Vronskaya M et al (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108–117PubMed
86.
Gerrish A, Rossi G, Richards A et al (2012) The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer’s disease. J Alzheimers Dis 28:377–387PubMedPubMedCentral
87.
Allen M, Kachadoorian M, Quicksall Z et al (2014) Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels. Alzheimer Res Ther 6:39–52
88.
Maeda S, Djukic B, Taneja P et al (2016) Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice. EMBO Rep 17:530–551PubMedPubMedCentral
89.
Thal DB, Rüb U, Orantes M, Braak H (2002) Phases of Aβ deposition in the human brain and its relevance for the development of AD. Neurology 58:1
Metadata
Title
The puzzle of preserved cognition in the oldest old
Author
Orso Bugiani
Publication date
01-02-2020
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 2/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-04111-y

Other articles of this Issue 2/2020

Neurological Sciences 2/2020 Go to the issue

Highlights

Highlights of the issue 2, 2020

Original Article

Optic nerve sheath diameter asymmetry in healthy subjects and patients with intracranial hypertension

Letter to the Editor

Room tilt illusion and persistent hiccups as presenting symptoms of a left PICA stroke: a case report

Original Article

Clinical characteristics and long-term follow-up of seven cases of anti-GABABR encephalitis in patients of Han Chinese descent

Review Article

Central mimics of benign paroxysmal positional vertigo: an illustrative case series

Brief Communication

The hidden information in patient-reported outcomes and clinician-assessed outcomes: multiple sclerosis as a proof of concept of a machine learning approach